Bioporto has filed for more US patents, all related to measurement of NGAL. One thing strikes you when you look at the various applications.
Take a look for yourself – if at first you don´t see the common denominator scroll down
Exclusion patent.
The ratio patent:
The CutOff patent:
scroll […]
Another interesting article about NGAL as a marker for AKI, from the University of Liege
NGAL biomarqueur de lésion rénale
Docteur at Hospital du Nord in Saint Etienne France Amandine Gagneux-Brunon and Belgian Docteurs at the University of Liege , Pierre Delanaye, Delphine LeGrand, Etienne Cavalier and Christophe Mariat have made an interesting article about the potential […]
Dr. Devarajan has made a more comprehensive explanation of the nature of NGAL , the presentation is from 2010 – and since then Alere (Biosite) and Abbott has brought their test to the market.
Please note the cutoff-value mentioned (100) and bear in mind that you will find healthy individuals up to […]
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard

